0,883  0,003  Cardiovascular analeptic
0,765  0,016  Caspase 9 stimulant
0,727  0,004  UGT1A4 substrate
0,709  0,010  Respiratory analeptic
0,685  0,008  5 Hydroxytryptamine release stimulant
0,670  0,001  Cathepsin L2 inhibitor
0,698  0,031  Apoptosis agonist
0,660  0,010  Sensitization
0,646  0,008  Immunosuppressant
0,640  0,019  TNF expression inhibitor
0,627  0,011  Analeptic
0,617  0,005  Antineoplastic (endocrine cancer)
0,646  0,042  Antiinflammatory
0,613  0,033  Antineoplastic (breast cancer)
0,596  0,019  Cholesterol antagonist
0,601  0,031  Transcription factor NF kappa B inhibitor
0,559  0,009  UDP-glucuronosyltransferase substrate
0,577  0,033  Antineoplastic (lung cancer)
0,556  0,018  Antipruritic, allergic
0,552  0,015  AR expression inhibitor
0,537  0,004  Antiviral (Influenza)
0,526  0,009  Sedative
0,518  0,009  ICAM1 expression inhibitor
0,526  0,017  NOS3 expression inhibitor
0,541  0,035  CYP3A4 substrate
0,527  0,023  Antineoplastic (ovarian cancer)
0,499  0,004  Antiviral (Influenza A)
0,495  0,005  Antiparkinsonian, rigidity relieving
0,508  0,020  Antifungal
0,490  0,004  Lipocortins synthesis antagonist
0,480  0,006  Abortion inducer
0,479  0,007  Contraceptive
0,493  0,025  CYP2C19 inhibitor
0,481  0,017  Nitric oxide antagonist
0,488  0,027  Antihypercholesterolemic
0,495  0,037  CYP2C9 substrate
0,480  0,023  Apoptosis antagonist
0,466  0,018  Cardiodepressant
0,451  0,008  Platelet adhesion inhibitor
0,438  0,006  Antipruritic, non-allergic
0,458  0,035  Ulceration
0,459  0,042  Antineoplastic (colorectal cancer)
0,454  0,040  Antineoplastic (colon cancer)
0,422  0,012  Sodium/bile acid cotransporter inhibitor
0,426  0,019  Antihypoxic
0,429  0,024  UGT2B4 substrate
0,421  0,018  Calcium channel activator
0,422  0,019  Vascular (periferal) disease treatment
0,442  0,039  Teratogen
0,411  0,010  Prostate disorders treatment
0,412  0,015  P-glycoprotein inhibitor
0,403  0,010  Antiacne
0,419  0,027  CYP3A4 inhibitor
0,398  0,011  Interferon gamma antagonist
0,421  0,038  Hepatic disorders treatment
0,397  0,014  Antiviral (Herpes)
0,408  0,027  Chemopreventive
0,408  0,031  NOS2 expression inhibitor
0,375  0,006  Gastrin inhibitor
0,403  0,037  Antineoplastic (pancreatic cancer)
0,419  0,058  Antileukemic
0,401  0,042  Embryotoxic
0,384  0,025  Psychostimulant
0,384  0,030  Antipyretic
0,361  0,009  Antiparkinsonian, tremor relieving
0,395  0,050  Antithrombotic
0,358  0,016  UGT2B7 substrate
0,353  0,012  Protein kinase stimulant
0,380  0,040  Antineoplastic (cervical cancer)
0,386  0,050  FMO1 substrate
0,343  0,010  Antidiarrheal
0,339  0,007  UGT2B9 substrate
0,375  0,045  CYP2C19 substrate
0,345  0,016  Anesthetic
0,402  0,077  5 Hydroxytryptamine release inhibitor
0,343  0,020  Hepatoprotectant
0,349  0,026  5 Hydroxytryptamine uptake stimulant
0,330  0,009  Cholesterol synthesis inhibitor
0,339  0,017  Prostatic (benign) hyperplasia treatment
0,343  0,024  Muscle relaxant
0,365  0,048  Lipoprotein disorders treatment
0,358  0,042  Cytotoxic
0,340  0,025  Growth hormone agonist
0,353  0,041  Cytostatic
0,316  0,005  Contraceptive female
0,356  0,052  Antineoplastic (melanoma)
0,335  0,033  Interleukin agonist
0,345  0,047  Antineoplastic (glioma)
0,342  0,044  Antineoplastic (multiple myeloma)
0,338  0,042  Proliferative diseases treatment
0,334  0,039  Hypolipemic
0,347  0,053  Antineoplastic (brain cancer)
0,313  0,020  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,330  0,036  Antiparasitic
0,311  0,018  Hair growth stimulant
0,295  0,003  Antirickettsial
0,302  0,017  Neurotrophic factor enhancer
0,332  0,048  Chemoprotective
0,321  0,039  UGT1A6 substrate
0,324  0,042  Antineoplastic (liver cancer)
0,341  0,068  Prostate cancer treatment
0,320  0,048  Antiprotozoal (Leishmania)
0,273  0,003  Adenylate cyclase stimulant
0,361  0,096  Antibacterial
0,330  0,066  Caspase 3 stimulant
0,358  0,096  Histamine release inhibitor
0,284  0,024  Skeletal muscle relaxant
0,303  0,044  Carcinogenic
0,301  0,043  DNA synthesis inhibitor
0,337  0,080  Vasodilator, peripheral
0,262  0,006  Microtubule formation inhibitor
0,286  0,030  VCAM1 expression inhibitor
0,288  0,034  RNA-directed DNA polymerase inhibitor
0,258  0,004  Arachidonic acid antagonist
0,263  0,010  UGT2B10 substrate
0,274  0,022  UGT2B15 substrate
0,309  0,058  Antioxidant
0,286  0,036  UGT1A1 substrate
0,261  0,015  Antifungal enhancer
0,251  0,009  Antispirochetal
0,308  0,067  Cardioprotectant
0,285  0,048  Antimitotic
0,310  0,076  Immunostimulant
0,238  0,005  Pregnane X receptor agonist
0,252  0,020  Toxic, respiratory center
0,237  0,005  Actinic keratosis treatment
0,283  0,061  GST M1-1 substrate
0,232  0,011  Cyclooxygenase 3 inhibitor
0,233  0,014  Endometrios treatment
0,291  0,074  Spasmolytic
0,225  0,008  Antineoplastic alkaloid
0,256  0,043  Antihelmintic
0,314  0,103  GST A substrate
0,215  0,004  Glycine receptor agonist
0,287  0,079  CYP2D6 inhibitor
0,235  0,030  Skin irritative effect
0,267  0,062  Angiogenesis stimulant
0,239  0,035  Antihelmintic (Nematodes)
0,247  0,047  Antialcoholic
0,226  0,027  Alpha-N-acetylglucosaminidase inhibitor
0,202  0,004  Anabolic
0,349  0,152  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,248  0,051  Anesthetic general
0,212  0,018  Expectorant
0,278  0,086  CTGF expression inhibitor
0,196  0,004  Ca2+-transporting ATPase inhibitor
0,215  0,024  Antihyperlipoproteinemic
0,204  0,014  Antiinfertility, female
0,228  0,042  Antiviral (Hepatitis)
0,195  0,010  ABCA1 expression enhancer
0,208  0,024  Adenylate cyclase inhibitor
0,188  0,005  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,217  0,035  Phospholipase C inhibitor
0,257  0,075  Antineoplastic (renal cancer)
0,245  0,064  Antineoplastic (glioblastoma multiforme)
0,258  0,077  Transcription factor STAT3 inhibitor
0,283  0,102  Vasodilator, coronary
0,271  0,094  Antimycobacterial
0,245  0,069  Antineoplastic (lymphoma)
0,275  0,099  Bone diseases treatment
0,227  0,053  Pneumotoxic
0,189  0,016  Antineoplastic, alkylator
0,177  0,004  Potassium channel Kv1.3 blocker
0,208  0,036  Interleukin 6 antagonist
0,209  0,037  Melanin inhibitor
0,259  0,087  Radioprotector
0,208  0,037  Antiviral (Hepatitis C)
0,181  0,011  Transcription factor NF kappa B stimulant
0,191  0,021  SULT1A1 substrate
0,250  0,083  UGT1A9 substrate
0,221  0,054  Insulin sensitizer
0,204  0,037  Antiseptic
0,166  0,003  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,170  0,009  UGT2B11 substrate
0,184  0,022  Growth stimulant
0,186  0,026  Antihemorrhagic
0,206  0,048  UGT1A3 substrate
0,217  0,059  Non-steroidal antiinflammatory agent
0,167  0,012  Keratolytic
0,239  0,087  Aldehyde oxidase inhibitor
0,202  0,053  VEGF expression inhibitor
0,167  0,018  Androgen antagonist
0,155  0,007  Androgen agonist
0,157  0,009  Ornithine decarboxylase inhibitor
0,153  0,005  Anticholelithogenic
0,158  0,012  Aromatase inhibitor
0,218  0,072  Antihypertriglyceridemic
0,155  0,010  Antiprotozoal activity enhancer
0,167  0,022  HDL-cholesterol increasing
0,167  0,023  UGT2B1 substrate
0,256  0,113  Interleukin 2 agonist
0,149  0,008  Glycine receptor antagonist
0,247  0,108  CYP2D6 substrate
0,242  0,108  Hypoxia-inducible factor 1 alpha inhibitor
0,151  0,017  GST T1-1 substrate
0,140  0,008  Na+ K+ transporting ATPase inhibitor
0,136  0,007  Oxytocin antagonist
0,222  0,094  Hypoglycemic
0,230  0,103  Antiosteoporotic
0,178  0,051  Lipid peroxidase inhibitor
0,186  0,059  Antipruritic
0,139  0,013  Glutamate release inhibitor
0,154  0,028  Photosensitizer
0,141  0,015  Tourette's syndrome treatment
0,155  0,030  Alcohol dehydrogenase substrate
0,190  0,065  Diabetic nephropathy treatment
0,154  0,030  Anticataract
0,141  0,019  Paget's disease treatment
0,152  0,030  TRPA1 agonist
0,126  0,004  Postcoital contraceptive
0,183  0,061  Antimutagenic
0,217  0,095  Tumour necrosis factor alpha release inhibitor
0,123  0,003  Adenylate cyclase 1 inhibitor
0,163  0,043  Anesthetic local
0,142  0,023  Acetylcholine nicotinic antagonist
0,219  0,101  DNA damaging
0,151  0,032  Choleretic
0,153  0,036  Menstruation disorders treatment
0,177  0,061  Eye irritation, high
0,149  0,033  Mucolytic
0,162  0,046  Cocaine dependence treatment
0,126  0,010  Narcotic antagonist
0,177  0,062  ATPase inhibitor
0,170  0,056  Insulin secretagoues
0,151  0,039  Carcinogenic, group 2B
0,139  0,027  Prolactin inhibitor
0,140  0,033  UDP-glucose 4-epimerase inhibitor
0,148  0,041  Glutathione S-transferase substrate
0,260  0,153  CYP2C9 inhibitor
0,111  0,005  SULT2A1 substrate
0,117  0,011  Estrogen-related receptor beta agonist
0,126  0,020  Tocolytic
0,162  0,057  CF transmembrane conductance regulator agonist
0,153  0,048  Farnesoid X receptor antagonist
0,113  0,009  Antimycoplasmal
0,150  0,047  Proteasome inhibitor
0,166  0,063  Acaricide
0,111  0,009  5-Alpha-reductase inhibitor
0,150  0,049  Retinoprotector
0,159  0,060  Antineoplastic (squamous cell carcinoma)
0,214  0,116  Antituberculosic
0,125  0,028  Thioredoxin inhibitor
0,133  0,036  Sulfotransferase substrate
0,146  0,049  Antismoking
0,130  0,034  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,137  0,042  Antiviral (Poxvirus)
0,217  0,121  Radiosensitizer
0,122  0,028  Lanosterol 14 alpha demethylase inhibitor
0,099  0,005  Anesthetic inhalation
0,099  0,005  Acetyl-CoA transferase 2 inhibitor
0,212  0,122  Transcription factor STAT inhibitor
0,094  0,007  Lipocortins synthesis agonist
0,114  0,026  Bile acid receptor antagonist
0,169  0,082  Succinate dehydrogenase inhibitor
0,109  0,024  Nicotinic alpha4beta2 receptor antagonist
0,087  0,005  Pregnane X receptor antagonist
0,150  0,069  Antineoplastic (carcinoma)
0,096  0,015  Uterine relaxant
0,134  0,053  Autism spectrum disorders treatment
0,092  0,012  Botulinum neurotoxin type A inhibitor
0,083  0,004  Microtubule stabilization
0,180  0,104  Antiulcerative
0,211  0,135  Antipsoriatic
0,087  0,011  Heme oxygenase stimulant
0,106  0,031  Contraceptive male
0,132  0,058  Coagulant
0,081  0,008  RNA-directed RNA polymerase stimulant
0,215  0,142  FMO3 substrate
0,094  0,022  Antidote, organophosphates
0,201  0,129  Flavin-containing monooxygenase substrate
0,185  0,116  Nitric-oxide synthase stimulant
0,111  0,042  Antineoplastic antibiotic
0,126  0,059  Protein-tyrosine phosphatase 1B inhibitor
0,087  0,021  Estrogen agonist
0,128  0,062  Antiviral (Hepatitis B)
0,209  0,143  CYP1A2 substrate
0,121  0,056  Antiviral (CMV)
0,161  0,096  LDLR expression enhancer
0,069  0,005  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,100  0,037  Inducible nitric-oxide synthase inhibitor
0,072  0,009  Vasopressin 2 antagonist
0,083  0,020  Nitric oxide donor
0,091  0,029  Premenstrual syndrome treatment
0,068  0,008  Farnesoid X receptor agonist
0,124  0,064  Beta amyloid protein antagonist
0,118  0,059  Estrogen antagonist
0,081  0,022  Postmenopausal disorders treatment
0,063  0,005  Vasopressin 1B antagonist
0,122  0,064  Antineoplastic antimetabolite
0,111  0,054  Toll-Like receptor 4 antagonist
0,125  0,068  Carcinogenic, group 3
0,125  0,069  Cholinergic antagonist
0,063  0,011  Vasopressin 1A antagonist
0,107  0,055  Chronic obstructive bronchitis treatment
0,099  0,048  Calcium antagonist
0,176  0,126  Vasodilator
0,119  0,069  Alkylator
0,125  0,076  Vanilloid 1 agonist
0,060  0,011  Parathyroid hormone antagonist
0,059  0,012  Glucocorticoid antagonist
0,118  0,072  Acetylcholine antagonist
0,076  0,030  Glutamate (mGluR6) antagonist
0,091  0,045  3C-Like protease (SARS coronavirus) inhibitor
0,083  0,038  Cushing's syndrome treatment
0,052  0,007  Tubulin agonist
0,127  0,084  CC chemokine 6 receptor antagonist
0,075  0,033  HIV-1 integrase (Strand Transfer) inhibitor
0,103  0,063  Adenylate kinase inhibitor
0,135  0,095  Mutagenic
0,050  0,010  Cholesterol absorption inhibitor
0,042  0,002  Telomerase stimulant
0,094  0,054  Triose-phosphate isomerase inhibitor
0,047  0,008  Cholesterol ester transfer protein antagonist
0,071  0,033  Hypercalcemia treatment
0,054  0,017  Progesterone antagonist
0,130  0,094  Genotoxic
0,102  0,067  AMP-activated protein kinase stimulant
0,078  0,044  Epoxide hydrolase inhibitor
0,078  0,045  CDC25A inhibitor
0,047  0,014  Glucose-6-phosphate dehydrogenase inhibitor
0,110  0,077  DNA polymerase I inhibitor
0,051  0,020  Guanylate cyclase inhibitor
0,055  0,024  Aldosterone antagonist
0,043  0,012  HMG CoA reductase inhibitor
0,091  0,061  SULT1E1 substrate
0,035  0,006  Progesterone agonist
0,035  0,006  Hedgehog signaling activator
0,100  0,072  Antiprotozoal (Toxoplasma)
0,045  0,016  Vasopressin 1 antagonist
0,206  0,178  Antineoplastic (osteosarcoma)
0,073  0,046  Phosphofructokinase-1 inhibitor
0,037  0,011  Elastase 2B inhibitor
0,037  0,011  Elastase 3B inhibitor
0,037  0,011  Elastase 3A inhibitor
0,031  0,006  Corticosteroid-like
0,040  0,015  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,033  0,009  5-Alpha-reductase 2 inhibitor
0,075  0,051  Antibiotic
0,056  0,032  Alpha-mannosidase inhibitor
0,052  0,027  Glucose-6-phosphate isomerase inhibitor
0,049  0,025  Opioid kappa receptor agonist
0,128  0,105  Acute respiratory distress syndrome (ARDS) treatment
0,043  0,022  GABA uptake inhibitor
0,032  0,010  Estrone sulfatase inhibitor
0,103  0,081  Antiviral (Coronavirus)
0,103  0,081  Antiviral (SARS coronavirus)
0,036  0,015  Glutamate (mGluR3) agonist
0,076  0,055  Estrogen receptor alpha antagonist
0,037  0,017  Carboxypeptidase B inhibitor
0,041  0,021  Arginase inhibitor
0,059  0,040  Sphingosine kinase inhibitor
0,028  0,009  5-Alpha-reductase 1 inhibitor
0,100  0,081  Interleukin 1b antagonist
0,077  0,058  Chymotrypsin inhibitor
0,040  0,022  Vanilloid 3 antagonist
0,203  0,185  Ca(v)3.3 blocker
0,118  0,100  Psychosexual dysfunction treatment
0,022  0,005  Vitamin D receptor agonist
0,042  0,026  Antidiuretic hormone antagonist
0,041  0,025  Membrane dipeptidase inhibitor
0,073  0,056  Vanilloid 4 agonist
0,026  0,009  Vitamin D receptor antagonist
0,049  0,034  Antiviral (Herpesvirus 3, Human)
0,059  0,044  Carbamoyl phosphate synthetase inhibitor
0,052  0,038  Protein 50S ribosomal subunit inhibitor
0,169  0,155  Antihypotensive
0,079  0,066  Antiviral (Trachoma)
0,059  0,046  Transcription factor AP-1 inhibitor
0,022  0,009  Progesterone receptor B antagonist
0,041  0,028  Liver X receptor alpha agonist
0,033  0,020  ATP citrate lysase inhibitor
0,065  0,053  Elastase 1 inhibitor
0,048  0,036  HCV NS3/NS4A protease inhibitor
0,090  0,079  GABA C receptor agonist
0,023  0,014  GRP78 expression inhibitor
0,051  0,042  Nicotinic alpha3beta2 receptor antagonist
0,065  0,056  Exportin-1 inhibitor
0,174  0,165  Antidiabetic (type 2)
0,052  0,043  Alcohol oxidase inhibitor
0,121  0,112  Protein-tyrosine phosphatase inhibitor
0,050  0,042  Acetyl-CoA transferase inhibitor
0,147  0,140  Potassium channel (Voltage-sensitive) blocker
0,080  0,072  Antileprosy
0,050  0,043  Acyl-CoA dehydrogenase inhibitor
0,151  0,144  Free radical scavenger
0,098  0,092  Acetylcholine release stimulant
0,047  0,041  Diacylglycerol O-acyltransferase inhibitor
0,011  0,005  Progesterone receptor A antagonist
0,120  0,114  Antidiabetic (type 1)
0,058  0,053  Antiviral (Parainfluenza)
0,035  0,029  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,012  0,008  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,039  0,035  Hypogonadism treatment
0,032  0,028  Retinoid X receptor agonist
0,027  0,023  1,3-Beta-glucan synthase inhibitor
0,234  0,230  Antidiabetic
0,234  0,230  Cyclophilin D inhibitor
0,024  0,020  Vanilloid 2 agonist
0,031  0,028  Retinoid X alpha receptor agonist
0,021  0,019  Retinoid X gamma receptor agonist
0,020  0,018  Retinoid X beta receptor antagonist
0,025  0,024  Retinoid X gamma receptor antagonist
0,058  0,058  Interferon inducer
0,031  0,030  Retinoid X alpha receptor antagonist
0,005  0,005  Transcortin receptor antagonist
0,034  0,034  Retinoid X receptor antagonist

